Bio-Polar

百极弘烨

Bio-Polar

Biotech/Healthcare

Baiji Hongye is a developer of innovative drugs for hematologic oncology. Through multiple R&D models—including independent innovation, collaborative development, and licensing—it pursues differentiated development of innovative drugs, aiming to create first-in-class or best-in-class Class 1 new…

Latest round: Series A (2021)

Source: ChinaBulls — chinabulls.com

Last updated 2021-10-01